- Home
- ICMB vs OVID Comparison
ICMB vs OVID Comparison
Compare ICMB & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICMB
- OVID
- Stock Information
- Founded
- ICMB 2012
- OVID 2014
- Country
- ICMB United States
- OVID United States
- Employees
- ICMB N/A
- OVID N/A
- Industry
- ICMB Finance: Consumer Services
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- ICMB Finance
- OVID Health Care
- Exchange
- ICMB Nasdaq
- OVID Nasdaq
- Market Cap
- ICMB 44.8M
- OVID 47.1M
- IPO Year
- ICMB N/A
- OVID 2017
- Fundamental
- Price
- ICMB $3.23
- OVID $0.31
- Analyst Decision
- ICMB
- OVID Strong Buy
- Analyst Count
- ICMB 0
- OVID 6
- Target Price
- ICMB N/A
- OVID $3.03
- AVG Volume (30 Days)
- ICMB 22.1K
- OVID 343.6K
- Earning Date
- ICMB 03-25-2025
- OVID 03-11-2025
- Dividend Yield
- ICMB 14.84%
- OVID N/A
- EPS Growth
- ICMB N/A
- OVID N/A
- EPS
- ICMB 0.45
- OVID N/A
- Revenue
- ICMB $23,360,165.00
- OVID $566,000.00
- Revenue This Year
- ICMB N/A
- OVID N/A
- Revenue Next Year
- ICMB N/A
- OVID $36.11
- P/E Ratio
- ICMB $7.17
- OVID N/A
- Revenue Growth
- ICMB N/A
- OVID 44.39
- 52 Week Low
- ICMB $2.91
- OVID $0.31
- 52 Week High
- ICMB $3.67
- OVID $3.45
- Technical
- Relative Strength Index (RSI)
- ICMB 50.78
- OVID 22.55
- Support Level
- ICMB $3.14
- OVID $0.42
- Resistance Level
- ICMB $3.30
- OVID $0.48
- Average True Range (ATR)
- ICMB 0.09
- OVID 0.05
- MACD
- ICMB -0.01
- OVID -0.01
- Stochastic Oscillator
- ICMB 38.57
- OVID 1.73
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.